1. Home
  2. KPTI vs RRGB Comparison

KPTI vs RRGB Comparison

Compare KPTI & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPTI
  • RRGB
  • Stock Information
  • Founded
  • KPTI 2008
  • RRGB 1969
  • Country
  • KPTI United States
  • RRGB United States
  • Employees
  • KPTI N/A
  • RRGB N/A
  • Industry
  • KPTI Biotechnology: Pharmaceutical Preparations
  • RRGB Restaurants
  • Sector
  • KPTI Health Care
  • RRGB Consumer Discretionary
  • Exchange
  • KPTI Nasdaq
  • RRGB Nasdaq
  • Market Cap
  • KPTI 81.1M
  • RRGB 91.6M
  • IPO Year
  • KPTI 2013
  • RRGB 2002
  • Fundamental
  • Price
  • KPTI $0.65
  • RRGB $5.12
  • Analyst Decision
  • KPTI Strong Buy
  • RRGB Strong Buy
  • Analyst Count
  • KPTI 4
  • RRGB 3
  • Target Price
  • KPTI $5.00
  • RRGB $12.50
  • AVG Volume (30 Days)
  • KPTI 694.6K
  • RRGB 289.5K
  • Earning Date
  • KPTI 02-27-2025
  • RRGB 02-26-2025
  • Dividend Yield
  • KPTI N/A
  • RRGB N/A
  • EPS Growth
  • KPTI N/A
  • RRGB N/A
  • EPS
  • KPTI N/A
  • RRGB N/A
  • Revenue
  • KPTI $148,442,000.00
  • RRGB $1,272,359,000.00
  • Revenue This Year
  • KPTI $5.47
  • RRGB N/A
  • Revenue Next Year
  • KPTI $6.33
  • RRGB $0.95
  • P/E Ratio
  • KPTI N/A
  • RRGB N/A
  • Revenue Growth
  • KPTI 1.77
  • RRGB N/A
  • 52 Week Low
  • KPTI $0.58
  • RRGB $2.97
  • 52 Week High
  • KPTI $1.70
  • RRGB $11.03
  • Technical
  • Relative Strength Index (RSI)
  • KPTI 46.51
  • RRGB 49.87
  • Support Level
  • KPTI $0.60
  • RRGB $5.70
  • Resistance Level
  • KPTI $0.70
  • RRGB $6.50
  • Average True Range (ATR)
  • KPTI 0.05
  • RRGB 0.31
  • MACD
  • KPTI -0.00
  • RRGB -0.04
  • Stochastic Oscillator
  • KPTI 46.61
  • RRGB 35.45

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

About RRGB Red Robin Gourmet Burgers Inc.

Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue.

Share on Social Networks: